These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23519253)
1. Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer. Liu Y; Gao X; Deeb D; Arbab AS; Gautam SC Molecules; 2012 Dec; 17(12):14795-809. PubMed ID: 23519253 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent. Deeb D; Gao X; Liu Y; Varma NR; Arbab AS; Gautam SC Molecules; 2013 Mar; 18(3):3250-65. PubMed ID: 23486104 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity. Deeb D; Gao X; Liu Y; Kim SH; Pindolia KR; Arbab AS; Gautam SC Biochem Biophys Res Commun; 2012 Jun; 422(4):561-7. PubMed ID: 22609405 [TBL] [Abstract][Full Text] [Related]
4. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR. Deeb D; Gao X; Jiang H; Dulchavsky SA; Gautam SC Prostate; 2009 Jun; 69(8):851-60. PubMed ID: 19189297 [TBL] [Abstract][Full Text] [Related]
8. CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells. Deeb D; Gao X; Dulchavsky SA; Gautam SC Anticancer Res; 2007; 27(5A):3035-44. PubMed ID: 17970042 [TBL] [Abstract][Full Text] [Related]
9. Induction of Apoptosis in Pancreatic Cancer Cells by CDDO-Me Involves Repression of Telomerase through Epigenetic Pathways. Deeb D; Brigolin C; Gao X; Liu Y; Pindolia KR; Gautam SC J Carcinog Mutagen; 2014 May; 5():177. PubMed ID: 25152840 [TBL] [Abstract][Full Text] [Related]
10. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway. Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702 [TBL] [Abstract][Full Text] [Related]
11. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. Deeb D; Gao X; Jiang H; Janic B; Arbab AS; Rojanasakul Y; Dulchavsky SA; Gautam SC Biochem Pharmacol; 2010 Feb; 79(3):350-60. PubMed ID: 19782051 [TBL] [Abstract][Full Text] [Related]
12. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Deeb D; Gao X; Liu Y; Jiang D; Divine GW; Arbab AS; Dulchavsky SA; Gautam SC Carcinogenesis; 2011 May; 32(5):757-64. PubMed ID: 21325633 [TBL] [Abstract][Full Text] [Related]
13. ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells. Gao X; Liu Y; Deeb D; Liu P; Liu A; Arbab AS; Gautam SC Anticancer Res; 2013 Jan; 33(1):215-21. PubMed ID: 23267148 [TBL] [Abstract][Full Text] [Related]
14. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Wu T; Ye Y; Min SY; Zhu J; Khobahy E; Zhou J; Yan M; Hemachandran S; Pathak S; Zhou XJ; Andreeff M; Mohan C Arthritis Rheumatol; 2014 Nov; 66(11):3129-39. PubMed ID: 25047252 [TBL] [Abstract][Full Text] [Related]
15. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells. Kim KB; Lotan R; Yue P; Sporn MB; Suh N; Gribble GW; Honda T; Wu GS; Hong WK; Sun SY Mol Cancer Ther; 2002 Jan; 1(3):177-84. PubMed ID: 12467212 [TBL] [Abstract][Full Text] [Related]
16. Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer. Gao X; Deeb D; Liu Y; Arbab AS; Divine GW; Dulchavsky SA; Gautam SC Cancers (Basel); 2011; 3(3):3353-69. PubMed ID: 21961053 [TBL] [Abstract][Full Text] [Related]
17. Role of telomerase in anticancer activity of pristimerin in prostate cancer cells. Liu YB; Gao X; Deeb D; Pindolia K; Gautam SC J Exp Ther Oncol; 2015; 11(1):41-9. PubMed ID: 26259389 [TBL] [Abstract][Full Text] [Related]
18. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling. Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329 [TBL] [Abstract][Full Text] [Related]
19. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer. Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762 [TBL] [Abstract][Full Text] [Related]
20. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]